Researchers are closely watching pozelimab, a novel treatment showing promising results in early clinical trials . This therapeutic targets aggregated tau – a significant hallmark of Alzheimer's disease https://opensocialfactory.com/story26552118/pozelimab-a-new-breakthrough-for-alzheimer-s